Parametric Portfolio Associates’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $119K | Sell |
43,123
-321,603
| -88% | -$887K | ﹤0.01% | 3539 |
|
|
2021
Q4 | $1.7M | Buy |
364,726
+291,040
| +395% | +$1.36M | ﹤0.01% | 2535 |
|
|
2021
Q3 | $627K | Buy |
73,686
+16,696
| +29% | +$142K | ﹤0.01% | 3002 |
|
|
2021
Q2 | $935K | Buy |
56,990
+790
| +1% | +$13K | ﹤0.01% | 2796 |
|
|
2021
Q1 | $1.24M | Sell |
56,200
-752
| -1% | -$16.6K | ﹤0.01% | 3057 |
|
|
2020
Q4 | $1.76M | Buy |
56,952
+5
| +0% | +$155 | ﹤0.01% | 2742 |
|
|
2020
Q3 | $1.16M | Buy |
56,947
+5,318
| +10% | +$108K | ﹤0.01% | 2825 |
|
|
2020
Q2 | $793K | Buy |
51,629
+12,623
| +32% | +$194K | ﹤0.01% | 3044 |
|
|
2020
Q1 | $302K | Buy |
39,006
+6,261
| +19% | +$48.5K | ﹤0.01% | 3400 |
|
|
2019
Q4 | $468K | Buy |
32,745
+25
| +0.1% | +$357 | ﹤0.01% | 3392 |
|
|
2019
Q3 | $492K | Sell |
32,720
-2,324
| -7% | -$34.9K | ﹤0.01% | 3356 |
|
|
2019
Q2 | $501K | Buy |
35,044
+6,672
| +24% | +$95.4K | ﹤0.01% | 3363 |
|
|
2019
Q1 | $495K | Buy |
+28,372
| New | +$495K | ﹤0.01% | 3345 |
|